Today: 20 May 2026
Prudential share price edges up after buyback update as March results near
29 January 2026
1 min read

Prudential share price edges up after buyback update as March results near

London, Jan 29, 2026, 09:21 GMT — Regular session

  • Shares up 0.4% in early trade at 1,203.5 pence
  • Prudential said it bought back 283,602 shares on Wednesday for cancellation
  • Full-year results are due on March 19 in Hong Kong, March 18 in the UK

Prudential plc (PRU.L) shares rose in early London trading on Thursday after the insurer disclosed another round of share repurchases. The stock was up 0.4% at 1,203.5 pence, having traded between 1,196.5 and 1,206.0 on the day, data showed.

Prudential said it bought back 283,602 ordinary shares on Wednesday at prices between £11.8250 and £12.0250, averaging £11.9196, through J.P. Morgan Securities plc. The company said it plans to cancel the shares, leaving 2,542,768,285 shares in issue.

The daily buybacks sit inside a larger capital return push that management kicked off at the start of the year. Prudential said on Jan. 6 it would begin a share buyback programme of up to $1.2 billion, intended to be completed by no later than Dec. 18, 2026, and CEO Anil Wadhwani said the group remained “firmly focused on creating long-term shareholder value” alongside “consistent delivery of shareholder returns.” prudentialplc.com

The stock has been firm this week. Prudential closed at £11.99 on Wednesday, up 1.52%, even as the FTSE 100 fell 0.52%, MarketWatch data showed.

In a separate exchange filing on Wednesday, Prudential disclosed that non-executive director Arijit Basu has been recommended to become the non-executive director and chair of India’s IndusInd Bank with effect from Jan. 31, subject to shareholder approval.

Share buybacks are repurchases of a company’s own stock, typically for cancellation, which reduces the share count. Investors often read them as a signal of capital strength, though they do not change the underlying demand for insurance or the cycle in financial markets.

Still, the pace is not guaranteed. Prudential has said the timing and speed of returns can shift with market conditions, and the stock’s run towards its recent highs leaves it more exposed to any stumble in growth in its Asian businesses or a sharper swing in rates and risk assets.

The next hard catalyst for the shares is the 2025 full-year results release, scheduled for March 19 in Hong Kong (March 18 in the UK), according to the company’s financial calendar.

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus
Previous Story

Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus

Australia stock market today: ASX 200 slips as rare earths tumble, RBA rate call looms
Next Story

Australia stock market today: ASX 200 slips as rare earths tumble, RBA rate call looms

Go toTop